Do you think harmonisation is possible?
I do believe that we can achieve at least some level of harmonisation. More and more countries are launching their own medicinal cannabis program, such as France which just launched a very ambitious experimentation program. So I believe there is a momentum that can make things move in the right direction.
There is also the vote, that has unfortunately been postponed, of the United Nations’ Commission on Narcotic Drugs (CND) on six recommendations following a critical review of cannabis-related substances. If these substances are taken out of the list of Narcotic drugs and this is supported by a number of EU member states, this would be an important political message for us to go further.
What steps will you be taking next to achieve your goals?
We are in the process of contacting interested Members of European Parliament to create a working group in the parliament on the topic. We really want to be a cross-party committee. This working group will work as a forum to discuss and have exchanges with all the relevant stakeholders, experts, NGOs, patients association, and the European Commission.
From all this consultation, we will try to work on a common position we could defend in the Parliament.
If it all goes to plan, a further step, maybe for the second semester 2020, would be to have an initiative report on the topic at the Environment and Health Committee. This will be important in order to have a strong position on the topic and to get the Commission involved.